102 related articles for article (PubMed ID: 19527221)
1. N-terminal modification increases the stability of the recombinant human endostatin in vitro.
Jiang LP; Zou C; Yuan X; Luo W; Wen Y; Chen Y
Biotechnol Appl Biochem; 2009 Aug; 54(2):113-20. PubMed ID: 19527221
[TBL] [Abstract][Full Text] [Related]
2. Contributions of Zn(II)-binding to the structural stability of endostatin.
Han Q; Fu Y; Zhou H; He Y; Luo Y
FEBS Lett; 2007 Jun; 581(16):3027-32. PubMed ID: 17544408
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal integrity is critical for the stability and biological functions of endostatin.
Fu Y; Luo Y
Biochemistry; 2010 Aug; 49(30):6420-9. PubMed ID: 20545324
[TBL] [Abstract][Full Text] [Related]
4. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.
Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS
Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a monoPEG20000-Endostar.
Tong Y; Zhong K; Tian H; Gao X; Xu X; Yin X; Yao W
Int J Biol Macromol; 2010 Apr; 46(3):331-6. PubMed ID: 20122957
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant human endostatin induces apoptosis of human umbilical venous endothelial cells].
Yang F; He YL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):978-80. PubMed ID: 16864091
[TBL] [Abstract][Full Text] [Related]
8. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T
Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618
[TBL] [Abstract][Full Text] [Related]
9. Endostar induces apoptotic effects in HUVECs through activation of caspase-3 and decrease of Bcl-2.
Ling Y; Lu N; Gao Y; Chen Y; Wang S; Yang Y; Guo Q
Anticancer Res; 2009 Jan; 29(1):411-7. PubMed ID: 19331180
[TBL] [Abstract][Full Text] [Related]
10. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.
Ling Y; Yang Y; Lu N; You QD; Wang S; Gao Y; Chen Y; Guo QL
Biochem Biophys Res Commun; 2007 Sep; 361(1):79-84. PubMed ID: 17644065
[TBL] [Abstract][Full Text] [Related]
11. Engineering of a disulfide loop instead of a Zn binding loop restores the anti-proliferative, anti-angiogenic and anti-tumor activities of the N-terminal fragment of endostatin: Mechanistic and therapeutic insights.
Chamani R; Asghari SM; Alizadeh AM; Eskandari S; Mansouri K; Khodarahmi R; Taghdir M; Heidari Z; Gorji A; Aliakbar A; Ranjbar B; Khajeh K
Vascul Pharmacol; 2015 Sep; 72():73-82. PubMed ID: 26187352
[TBL] [Abstract][Full Text] [Related]
12. N-terminal fragment of the anti-angiogenic human endostatin binds copper(II) with very high affinity.
Kolozsi A; Jancsó A; Nagy NV; Gajda T
J Inorg Biochem; 2009 Jul; 103(7):940-7. PubMed ID: 19447499
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antiangiogenic activity of tetrandrine combined with Endostar on the human umbilical vein endothelial cell model.
Qian X; Yan B; Zhou X; Xie L; Wei J; Li R; Yu L; Liu B
Cancer Biother Radiopharm; 2013 Jun; 28(5):385-90. PubMed ID: 23682584
[TBL] [Abstract][Full Text] [Related]
14. Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin.
Veillard F; Saidi A; Burden RE; Scott CJ; Gillet L; Lecaille F; Lalmanach G
J Biol Chem; 2011 Oct; 286(43):37158-67. PubMed ID: 21896479
[TBL] [Abstract][Full Text] [Related]
15. Autophagic cell death of human hepatoma cells induced by endostar, a recombinant human endostatin.
Wu G; Zhang R; Ren J; Sun Y
Cancer Biother Radiopharm; 2008 Dec; 23(6):735-40. PubMed ID: 20443695
[TBL] [Abstract][Full Text] [Related]
16. A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity.
Tjin Tham Sjin RM; Satchi-Fainaro R; Birsner AE; Ramanujam VM; Folkman J; Javaherian K
Cancer Res; 2005 May; 65(9):3656-63. PubMed ID: 15867360
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states.
Xu WJ; Huang C; Wang J; Jiang RC; Wang LC; Lin L; Liu ZJ; Sun BC; Li K
Chin Med J (Engl); 2011 Sep; 124(18):2883-9. PubMed ID: 22040497
[TBL] [Abstract][Full Text] [Related]
18. Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism.
Ni Q; Ji H; Zhao Z; Fan X; Xu C
Eur J Pharmacol; 2009 Jul; 614(1-3):1-6. PubMed ID: 19389394
[TBL] [Abstract][Full Text] [Related]
19. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
Cho H; Kim WJ; Lee YM; Kim YM; Kwon YG; Park YS; Choi EY; Kim KW
Oncol Rep; 2004 Jan; 11(1):191-5. PubMed ID: 14654925
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog.
Wang S; Fu Y; Luo Y
Chin J Cancer; 2016 Jan; 35():14. PubMed ID: 26792627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
